Core Laboratories (CLB) to Release Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $0.20 per share and revenue of $130.4020 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Core Laboratories Trading Up 1.9%

NYSE:CLB opened at $19.68 on Wednesday. The company has a current ratio of 2.37, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. Core Laboratories has a 1-year low of $9.72 and a 1-year high of $20.36. The firm has a market capitalization of $916.30 million, a price-to-earnings ratio of 29.37, a PEG ratio of 16.86 and a beta of 1.03. The business’s 50-day moving average price is $17.05 and its two-hundred day moving average price is $14.10.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories currently has a consensus rating of “Hold” and an average price target of $12.50.

Institutional Trading of Core Laboratories

Several institutional investors have recently modified their holdings of CLB. Quantessence Capital LLC purchased a new stake in shares of Core Laboratories in the 3rd quarter valued at about $192,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Core Laboratories by 49.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,132 shares of the oil and gas company’s stock worth $199,000 after buying an additional 5,345 shares during the period. iSAM Funds UK Ltd purchased a new stake in Core Laboratories in the third quarter valued at approximately $202,000. Sei Investments Co. boosted its holdings in shares of Core Laboratories by 12.7% in the third quarter. Sei Investments Co. now owns 22,643 shares of the oil and gas company’s stock valued at $280,000 after acquiring an additional 2,550 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Core Laboratories by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock valued at $207,000 after acquiring an additional 1,040 shares during the period. Hedge funds and other institutional investors own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.